Pfizer Inc (PFE) 30.75 $PFE
1 Pipeline Stocked Full of Promise
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun May 04, 1:30PM CDT
In this segment from Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass look into Sanofi after its earnings report to discuss some of the biggest upcoming drugs in the company's pipeline. As the company's...
Buffalo Wild Wings' Wild Earnings, Twitter's Egg, Big M&A Drama, and the Week in Review
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Sat May 03, 6:00PM CDT
Before you toss back a couple of Dos Equis before Cinco de Mayo (or some Buds before the all-American Kentucky Derby), check out what pushed the Dow up to its first record high of 2014 this past week -- and anticipation of the big,...
This Week in Biotech: Merger Mania Continues
Sean Williams, The Motley Fool - Motley Fool - Sat May 03, 12:15PM CDT
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
Meet Lung Cancer's New Enemy
Todd Campbell, The Motley Fool - Motley Fool - Sat May 03, 9:00AM CDT
Novartis just won the FDA's approval for its new lung cancer drug, Zykadia, months ahead of schedule. The FDA's move reflects the significant need for new therapies designed to treat less common causes of cancer. In this case, the approval gives...
'Fast Money' Recap: Bullish or Bearish on Bonds?
at The Street - Sat May 03, 4:00AM CDT
The trading panel discussed energy companies and Berkshire Hathaway earnings.
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence...
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri May 02, 7:24PM CDT
Today's move into the red caught investors by surprise because the economy seems to be improving. Here's what Cramer will be watching next week.
Most active New York Stock Exchange-traded stocks
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
AstraZeneca rejects sweetened Pfizer takeover bid
By DANICA KIRKA and LINDA A. JOHNSON - AP - Fri May 02, 4:36PM CDT
LONDON (AP) — Pharmaceutical giant Pfizer said Friday that it hasn't given up on a deal after British drugmaker AstraZeneca flatly rejected its latest takeover bid, worth $106 billion.
Stocks finish lower on mixed earnings, Ukraine
By BERNARD CONDON - AP - Fri May 02, 4:29PM CDT
NEW YORK (AP) — The stock market ended lower on Friday as a surprisingly strong report on job gains failed to impress investors.
1 Comment
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems...
Business Highlights
By The Associated Press - AP - Fri May 02, 4:15PM CDT
___
Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 3:45PM CDT
Pfizer (PFE) has an Earnings ESP of -1.82% with a Zacks Rank #4 (Sell).
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.28%
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 1.28%, Pfizer Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why Pfizer Will Move the Dow Monday
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 3:30PM CDT
On Friday, the Dow Jones Industrials started out the day in record territory, with a big surge in April employment creating positive economic momentum for the stock market. But news that Russian President Vladimir Putin had called for a meeting...
Stocks Drop as Jobs Pop Is Offset by Troubling Details
at The Street - Fri May 02, 3:23PM CDT
U.S. stocks close lower Friday, erasing early gains after April's jobs report shows a lower work force participation rate. The United Nations is holding an emergency meeting over Ukraine as tensions rise in the region.
Big Pharma Deals Send Dow Lower
Travis Hoium, The Motley Fool - Motley Fool - Fri May 02, 2:30PM CDT
On a day when the Department of Labor issued a seemingly great jobs report, the Dow Jones Industrial Average was off 0.28% late in trading. A big reason is the index's two big pharma companies, Merck and Pfizer , falling as acquisition and...
Pfizer Inc. Earnings: Can They Grow Without AstraZeneca?
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
On Monday, Pfizer will release its quarterly report, and despite strong markets over the past year, the pharmaceutical giant's shares have stayed in a tight range. Investors are pondering how Pfizer can best foster growth in an increasingly...
1 Pipeline Stocked Full of Promise
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun May 04, 1:30PM CDT
In this segment from Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass look into Sanofi after its earnings report to discuss some of the biggest upcoming drugs in the company's pipeline. As the company's...
Buffalo Wild Wings' Wild Earnings, Twitter's Egg, Big M&A Drama, and the Week in Review
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Sat May 03, 6:00PM CDT
Before you toss back a couple of Dos Equis before Cinco de Mayo (or some Buds before the all-American Kentucky Derby), check out what pushed the Dow up to its first record high of 2014 this past week -- and anticipation of the big,...
This Week in Biotech: Merger Mania Continues
Sean Williams, The Motley Fool - Motley Fool - Sat May 03, 12:15PM CDT
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
Meet Lung Cancer's New Enemy
Todd Campbell, The Motley Fool - Motley Fool - Sat May 03, 9:00AM CDT
Novartis just won the FDA's approval for its new lung cancer drug, Zykadia, months ahead of schedule. The FDA's move reflects the significant need for new therapies designed to treat less common causes of cancer. In this case, the approval gives...
'Fast Money' Recap: Bullish or Bearish on Bonds?
at The Street - Sat May 03, 4:00AM CDT
The trading panel discussed energy companies and Berkshire Hathaway earnings.
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence...
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri May 02, 7:24PM CDT
Today's move into the red caught investors by surprise because the economy seems to be improving. Here's what Cramer will be watching next week.
Most active New York Stock Exchange-traded stocks
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
AstraZeneca rejects sweetened Pfizer takeover bid
By DANICA KIRKA and LINDA A. JOHNSON - AP - Fri May 02, 4:36PM CDT
LONDON (AP) — Pharmaceutical giant Pfizer said Friday that it hasn't given up on a deal after British drugmaker AstraZeneca flatly rejected its latest takeover bid, worth $106 billion.
Stocks finish lower on mixed earnings, Ukraine
By BERNARD CONDON - AP - Fri May 02, 4:29PM CDT
NEW YORK (AP) — The stock market ended lower on Friday as a surprisingly strong report on job gains failed to impress investors.
1 Comment
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems...
Business Highlights
By The Associated Press - AP - Fri May 02, 4:15PM CDT
___
Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 3:45PM CDT
Pfizer (PFE) has an Earnings ESP of -1.82% with a Zacks Rank #4 (Sell).
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.28%
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. After Yesterday's Decline of 1.28%, Pfizer Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. Why Pfizer Will Move the Dow Monday
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 3:30PM CDT
On Friday, the Dow Jones Industrials started out the day in record territory, with a big surge in April employment creating positive economic momentum for the stock market. But news that Russian President Vladimir Putin had called for a meeting...
Stocks Drop as Jobs Pop Is Offset by Troubling Details
at The Street - Fri May 02, 3:23PM CDT
U.S. stocks close lower Friday, erasing early gains after April's jobs report shows a lower work force participation rate. The United Nations is holding an emergency meeting over Ukraine as tensions rise in the region.
Big Pharma Deals Send Dow Lower
Travis Hoium, The Motley Fool - Motley Fool - Fri May 02, 2:30PM CDT
On a day when the Department of Labor issued a seemingly great jobs report, the Dow Jones Industrial Average was off 0.28% late in trading. A big reason is the index's two big pharma companies, Merck and Pfizer , falling as acquisition and...
Pfizer Inc. Earnings: Can They Grow Without AstraZeneca?
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
On Monday, Pfizer will release its quarterly report, and despite strong markets over the past year, the pharmaceutical giant's shares have stayed in a tight range. Investors are pondering how Pfizer can best foster growth in an increasingly...
